Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice-Reference-Cited by-同舟云学术

Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice

Published:2021-06 Issue:2 Volume:20 Page:101-112.e6
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Bang Yeong Hak,Hong Yong Sang,Lee Ji Sung,Lee Keun-Wook^ORCID,Han Hye Sook,Kim Sun Young,Kim Ji-Won,Kim Hee Kyung,Kim Jin Won,Eun Choi Ki,Kim Tae Won^ORCID,Kim Jeong Eun

Funder

Korea Foundation

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference19 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Metastatic colorectal cancer: current state and future directions;Fakih;J Clin Oncol,2015

3. Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis;Botrel;BMC Cancer,2016

4. Novel anti-angiogenic therapeutic strategies in colorectal cancer;Tampellini;Expert Opin Investig Drugs,2016

5. Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin® Registry–Investigation of Effectiveness and Safety (ARIES) observational cohort study;Hurwitz;Clin Oncol (R Coll Radiol),2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of bevacizumab on clinical outcomes and its comparison with standard chemotherapy in metastatic colorectal cancer patients: a systematic review and meta-analysis;Journal of Pharmaceutical Policy and Practice;2024-06-05

2. Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study;Cancers;2023-09-17

3. New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis;Biomedicine & Pharmacotherapy;2023-07

4. A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU;International Journal of Pharmaceutics;2022-07

5. Colorectal Cancer Heterogeneity and the Impact on Precision Medicine and Therapy Efficacy;Biomedicines;2022-04-30